Literature DB >> 19766958

Evidence of executive dysfunction in extremely obese adolescents: a pilot study.

Kristine Lee Lokken1, Abbe Gayle Boeka, Heather M Austin, John Gunstad, Carroll M Harmon.   

Abstract

BACKGROUND: Obesity in children and adolescents is 1 of the most urgent and serious health threats confronting the United States. Extremely obese adolescents (body mass index >99th percentile for age and gender) are a unique subgroup of obese youth who are at considerable medical and psychosocial risk. Little is known about the cognitive function of extremely obese adolescents. The present study sought to examine the cognitive performance of a sample of extremely obese adolescents seeking primary treatment for weight loss.
METHODS: Adolescents were recruited during regularly scheduled medical appointments at a children's center for weight management associated with a major children's hospital in the Southeast United States. A computerized battery of cognitive tests was administered to obese adolescents (body mass index >99th percentile; n = 25).
RESULTS: Obese adolescents exhibited deficits in many cognitive domains, including impairment in attention and executive functions (e.g., mental flexibility, disinhibition) compared with the normative data.
CONCLUSION: Although preliminary, these data have provided evidence for specific cognitive deficits in extremely obese adolescents. These findings highlight a need to determine whether early weight loss interventions, such as bariatric surgery, for obese adolescents could potentially prevent or reverse cognitive deficits and/or reduce the risk of future adverse neurocognitive outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19766958     DOI: 10.1016/j.soard.2009.05.008

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  52 in total

Review 1.  Can bariatric surgery reduce risk of Alzheimer's disease?

Authors:  Kelly M Stanek; John Gunstad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-07-04       Impact factor: 5.067

Review 2.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 3.  Impact of metabolic syndrome on cognition and brain: a selected review of the literature.

Authors:  Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

4.  Longitudinal examination of obesity and cognitive function: results from the Baltimore longitudinal study of aging.

Authors:  John Gunstad; April Lhotsky; Carrington Rice Wendell; Luigi Ferrucci; Alan B Zonderman
Journal:  Neuroepidemiology       Date:  2010-03-18       Impact factor: 3.282

5.  Saliency processing and obesity: a preliminary imaging study of the stop signal task.

Authors:  Olivia M Hendrick; Xi Luo; Sheng Zhang; Chiang-Shan R Li
Journal:  Obesity (Silver Spring)       Date:  2011-06-30       Impact factor: 5.002

Review 6.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

Review 7.  Human cognitive function and the obesogenic environment.

Authors:  Ashley A Martin; Terry L Davidson
Journal:  Physiol Behav       Date:  2014-03-11

Review 8.  The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms.

Authors:  Michael L Alosco; John Gunstad
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

Review 9.  Obesity-associated biomarkers and executive function in children.

Authors:  Alison L Miller; Hannah J Lee; Julie C Lumeng
Journal:  Pediatr Res       Date:  2014-10-13       Impact factor: 3.756

Review 10.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.